key: cord-1006630-5a0wd0bg
authors: Orta, Nelson; Alvarado, Amado
title: Response to Morreale
date: 2021-10-14
journal: Pediatr Nephrol
DOI: 10.1007/s00467-021-05308-0
sha: 82e953147ad3a3c0ac68dde3f1466b8d71137b68
doc_id: 1006630
cord_uid: 5a0wd0bg

nan

Dear Editors, As a response to the letter to the editor with additional and important information from Drs. A Morreale and ML Casciana, who report a new pediatric case of C19 and onset of nephrotic syndrome (NS), we want to make some comments.

Certainly, in 2020, 2 reports were published (including our case) almost simultaneously of pediatric cases of the two entities and there could be relevance in their association. In our article, we preferred to keep an open mind before making a definitive statement of a possible relationship. Secondly, there is the relevant fact that in adult patients with C19 and severe kidney involvement, significant proteinuria has been found [1] .

It is not clear whether the NS is secondary to C19; however, there is a possible association in light of recent reports [2] and we know this topic is under further investigation. Another related and important aspect, and also highly worrying, is the observation of the development of NS in some people vaccinated with the mRNA-SARS-CoV-2 vaccine [3] . It could be speculated that the virus or related particles could have provoked kidney lesions that affected the glomerular filtration barrier and produced proteinuria. However, further studies are necessary, and some are already in progress. Additionally, it is important to investigate routine kidney function and the level of proteinuria in patients with C19 in order to obtain additional data and, eventually, more insight into this issue.

COVID-19-associated nephritis: early warning for disease severity and complications?

COVID-19 in children with nephrotic syndrome on anti-CD20 chronic immunosuppression

De novo and relapsing glomerular diseases after C-19 vaccination: what do we know so far?